What is Blue Biofuels Inc's earnings per share (EPS)?

Blue Biofuels Inc (BIOF) reported diluted earnings per share of $-0.01 for fiscal year 2025. This represents a -80.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Blue Biofuels Inc Financials

BIOF

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Blue Biofuels Inc (BIOF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BIOF FY2025 2026-05-04

A research-led cost base and persistent cash burn make external financing the company’s main source of continuity.

Operating cash burn improved to -$845K in FY2025 from -$1.0M in FY2024. Yet operating loss remained around -$3.7M, so accounting losses are running far ahead of cash use; that usually reflects a mix of non-cash charges and a cost structure that still lacks self-funding scale.

External financing is functioning as the operating bridge: FY2025 financing inflow of $999K slightly exceeded free cash outflow of -$914K. Shares outstanding rose to 317.9M from 308.0M over the last two years, suggesting that keeping operations going has required new capital rather than cash generated inside the business.

This is a low-capital-intensity setup: capital spending was only $69K in FY2025 versus R&D of $2.3M. Most cash needs therefore come from running the organization, not from building assets, while liquidity remains thin with $65K of cash against $3.0M of current liabilities.

Financial Health Signals

Financial health score pending refresh

We are recalculating Blue Biofuels Inc's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Piotroski F-Score Partial

1/6

Blue Biofuels Inc passes 1 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality Low Quality

0.29x

For every $1 of reported earnings, Blue Biofuels Inc generates $0.29 in operating cash flow (-$845K OCF vs -$2.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

-$3.6M

YoY+9.4%

Blue Biofuels Inc's EBITDA was -$3.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 9.4% from the prior year.

Net Income

-$2.9M

YoY-102.6%

Blue Biofuels Inc reported -$2.9M in net income in fiscal year 2025. This represents a decrease of 102.6% from the prior year.

EPS (Diluted)

$-0.01

YoY-80.0%

Blue Biofuels Inc earned $-0.01 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 80.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$914K

YoY+15.0%

Blue Biofuels Inc generated -$914K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 15.0% from the prior year.

Cash & Debt

$65K

YoY+33.6%

5Y CAGR-25.6%

Blue Biofuels Inc held $65K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

318M

YoY+3.2%

5Y CAGR+5.6%

10Y CAGR+22.9%

Blue Biofuels Inc had 318M shares outstanding in fiscal year 2025. This represents an increase of 3.2% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

$2.3M

YoY-1.0%

5Y CAGR+24.7%

Blue Biofuels Inc invested $2.3M in research and development in fiscal year 2025. This represents a decrease of 1.0% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$69K

YoY-3.1%

5Y CAGR-14.1%

10Y CAGR-6.8%

Blue Biofuels Inc invested $69K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 3.1% from the prior year.

BIOF Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$2.3M-1.0%	$2.3M+25.9%	$1.8M-21.3%	$2.4M+113.0%	$1.1M+44.6%	$763K
SG&A Expenses	$1.4M-18.3%	$1.7M+28.8%	$1.3M-13.1%	$1.5M+49.0%	$1.0M-15.7%	$1.2M
Operating Income	-$3.7M+8.4%	-$4.1M-27.1%	-$3.2M+18.9%	-$3.9M-81.1%	-$2.2M-9.1%	-$2.0M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$2.9M-102.6%	-$1.4M+53.6%	-$3.1M+22.9%	-$4.0M-85.1%	-$2.1M+1.9%	-$2.2M
EPS (Diluted)	$-0.01-80.0%	$-0.01+50.0%	$-0.01	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$385K	N/A	$486K+3.0%	$471K+34.4%	$351K	N/A	$411K+41.0%	$291K
SG&A Expenses	$275K	N/A	$351K-18.7%	$431K+27.5%	$338K	N/A	$237K-5.1%	$250K
Operating Income	-$659K	N/A	-$836K+7.4%	-$903K-31.0%	-$689K	N/A	-$648K-19.7%	-$541K
Interest Expense	$4K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$664K	N/A	-$423K+54.1%	-$921K-277.6%	-$244K	N/A	$1.9M+440.0%	-$549K
EPS (Diluted)	$-0.00	N/A	$-0.00+66.7%	$-0.00-200.0%	$-0.00	N/A	$0.01+400.0%	$-0.00

BIOF Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$1.4M+1.3%	$1.4M+34.9%	$1.0M-6.8%	$1.1M-39.8%	$1.8M+106.0%	$893K
Current Assets	$77K-5.6%	$81K+5.9%	$77K-69.9%	$255K-78.9%	$1.2M+264.5%	$332K
Cash & Equivalents	$65K+33.6%	$49K+19.0%	$41K-80.6%	$212K-81.8%	$1.2M+306.4%	$287K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$5.1M+20.7%	$4.2M-7.7%	$4.6M+32.6%	$3.5M+7.1%	$3.2M-23.5%	$4.2M
Current Liabilities	$3.0M+34.9%	$2.2M+47.2%	$1.5M+135.3%	$639K+28.7%	$496K-54.8%	$1.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	$100K
Total Equity	-$3.7M-30.2%	-$2.8M+20.1%	-$3.6M-51.1%	-$2.4M-68.8%	-$1.4M+58.2%	-$3.3M
Retained Earnings	-$60.1M-5.0%	-$57.3M-2.5%	-$55.8M-5.8%	-$52.8M-8.1%	-$48.8M-4.6%	-$46.7M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$1.3M-6.9%	$1.4M-5.3%	$1.5M+2.6%	$1.4M-2.3%	$1.5M+6.7%	$1.4M-6.7%	$1.5M+14.1%	$1.3M
Current Assets	$20K-73.7%	$77K-28.0%	$107K+447.5%	$19K-51.4%	$40K-50.7%	$81K-62.4%	$216K-50.9%	$440K
Cash & Equivalents	$9K-86.7%	$65K-31.5%	$95K+1086.1%	$8K+5.8%	$8K-84.5%	$49K-67.3%	$149K-63.4%	$408K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$5.2M+2.6%	$5.1M+12.5%	$4.5M-1.7%	$4.6M+4.2%	$4.4M+4.7%	$4.2M+5.9%	$4.0M-34.0%	$6.1M
Current Liabilities	$3.1M+4.5%	$3.0M+24.7%	$2.4M-2.3%	$2.5M+5.2%	$2.3M+5.3%	$2.2M+12.9%	$2.0M-1.5%	$2.0M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$3.9M-6.2%	-$3.7M-21.2%	-$3.1M+3.6%	-$3.2M-7.5%	-$3.0M-3.7%	-$2.8M-13.3%	-$2.5M+47.1%	-$4.8M
Retained Earnings	-$60.8M-1.1%	-$60.1M-2.2%	-$58.8M-0.7%	-$58.4M-1.6%	-$57.5M-0.4%	-$57.3M-3.2%	-$55.5M+3.3%	-$57.3M

BIOF Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$845K+15.8%	-$1.0M+37.3%	-$1.6M+21.4%	-$2.0M+17.4%	-$2.5M-167.5%	-$921K
Capital Expenditures	$69K-3.1%	$71K-75.3%	$288K+108.3%	$138K-36.1%	$216K+47.0%	$147K
Free Cash Flow	-$914K+15.0%	-$1.1M+43.1%	-$1.9M+13.2%	-$2.2M+18.9%	-$2.7M-150.9%	-$1.1M
Investing Cash Flow	-$137K-18.6%	-$116K+63.9%	-$321K-55.9%	-$206K+11.8%	-$233K-13.0%	-$206K
Financing Cash Flow	$999K-11.4%	$1.1M-35.6%	$1.8M+35.8%	$1.3M-64.0%	$3.6M+174.3%	$1.3M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$419K-6.7%	-$392K-154.8%	-$154K+50.7%	-$312K-2426.6%	$13K+106.3%	-$212K+14.5%	-$248K+13.7%	-$288K
Capital Expenditures	$105K+10463100.0%	-$1+100.0%	-$67K-313.4%	$32K-69.9%	$105K	N/A	N/A	N/A
Free Cash Flow	-$523K-33.4%	-$392K-77.3%	-$221K+35.6%	-$344K-276.8%	-$91K	N/A	N/A	N/A
Investing Cash Flow	-$10K+1.8%	-$10K-115.4%	$66K+271.0%	-$39K+75.0%	-$155K-80.7%	-$86K-722.3%	-$10K-1140.5%	$1K
Financing Cash Flow	$372K-0.1%	$373K+112.9%	$175K-50.2%	$351K+251.3%	$100K-49.2%	$197K	$0-100.0%	$670K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

BIOF Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-204.3%-102.1pp	-102.1%+194.4pp	-296.6%+61.5pp	-358.1%-241.7pp	-116.4%+128.0pp	-244.4%
Current Ratio	0.03-0.0	0.04-0.0	0.05-0.3	0.40-2.0	2.44+2.1	0.30
Debt-to-Equity	-1.38+0.1	-1.49-0.2	-1.29+0.2	-1.47+0.8	-2.32-2.3	-0.03
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-50.7%	N/A	-28.4%+35.2pp	-63.6%-47.1pp	-16.4%	N/A	125.3%+167.4pp	-42.0%
Current Ratio	0.01-0.0	0.03-0.0	0.04+0.0	0.010.0	0.02-0.0	0.04-0.1	0.11-0.1	0.22
Debt-to-Equity	-1.33+0.0	-1.38+0.1	-1.49-0.0	-1.46+0.0	-1.50-0.0	-1.49+0.1	-1.59-0.3	-1.27
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$3.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.03), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Nano One Materia NNOMF

$61.1M

Graphene Mfg Gro GMGMF

$220.0M

Kraig Biocraft Laboratories In KBLB

$116.6M

Airboss Of Ameri ABSSF

$133.7M

Greystone Logist GLGI

$5.7M

Frequently Asked Questions

Is Blue Biofuels Inc profitable?

No, Blue Biofuels Inc (BIOF) reported a net income of -$2.9M in fiscal year 2025.

What is Blue Biofuels Inc's EBITDA?

Blue Biofuels Inc (BIOF) had EBITDA of -$3.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Blue Biofuels Inc's free cash flow?

Blue Biofuels Inc (BIOF) generated -$914K in free cash flow during fiscal year 2025. This represents a 15.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Blue Biofuels Inc's operating cash flow?

Blue Biofuels Inc (BIOF) generated -$845K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Blue Biofuels Inc's total assets?

Blue Biofuels Inc (BIOF) had $1.4M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Blue Biofuels Inc's capital expenditures?

Blue Biofuels Inc (BIOF) invested $69K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Blue Biofuels Inc spend on research and development?

Blue Biofuels Inc (BIOF) invested $2.3M in research and development during fiscal year 2025.

How many shares does Blue Biofuels Inc have outstanding?

Blue Biofuels Inc (BIOF) had 318M shares outstanding as of fiscal year 2025.

What is Blue Biofuels Inc's current ratio?

Blue Biofuels Inc (BIOF) had a current ratio of 0.03 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Blue Biofuels Inc's debt-to-equity ratio?

Blue Biofuels Inc (BIOF) had a debt-to-equity ratio of -1.38 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Blue Biofuels Inc's return on assets (ROA)?

Blue Biofuels Inc (BIOF) had a return on assets of -204.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Blue Biofuels Inc's cash runway?

Based on fiscal year 2025 data, Blue Biofuels Inc (BIOF) had $65K in cash against an annual operating cash burn of $845K. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Blue Biofuels Inc's debt-to-equity ratio negative or unusual?

Blue Biofuels Inc (BIOF) has negative shareholder equity of -$3.7M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Blue Biofuels Inc's Piotroski F-Score?

Blue Biofuels Inc (BIOF) has a Piotroski F-Score of 1 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Blue Biofuels Inc's earnings high quality?

Blue Biofuels Inc (BIOF) has an earnings quality ratio of 0.29x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.